Tumors with deficient mismatch repair (dMMR)/MSI can result from germline mutations in the MMR genes (MLH1, MSH2, MSH6, PMS2), i.e., Lynch syndrome, or more often from epigenetic inactivation of the MMR genes. This evidence concerns the gene MRC1 and Lynch syndrome.